학술논문
Safety and Efficacy of Dacomitinib in Korean Patients with KRAS Wild-Type Advanced Non–Small-Cell Lung Cancer Refractory to Chemotherapy and Erlotinib or Gefitinib: A Phase I/II Trial
Document Type
Article
Author
Source
In Journal of Thoracic Oncology October 2014 9(10):1523-1531
Subject
Language
ISSN
1556-0864